Dear Climb community,
As you continue to make adjustments in response to the COVID-19 global pandemic, so too is the Climb to Fight Cancer. After postponing all of our 2020 climbs, we are offering domestic 2021 climbs to the adventurers postponed in 2020. Our guide services have made adjustments to provide for social distancing. Please email firstname.lastname@example.org for more information.
We need fearless science now more than ever. Hutch scientists are on the frontlines of this pandemic, balancing this urgent work with our core mission of advancing discoveries and curing cancer. I want to share an update with you about some of their exciting new research. Dr. Julie McElrath is leading the Seattle COVID-19 Cohort Study, which aims to decode the interaction between the virus and the immune system by studying people who are at high risk of exposure, as well as those who have already contracted the disease. Dr. Neelendu “Neel” Dey is piloting a “fail fast” study to explore whether it’s possible to target the microbiome to help patients recover more quickly or reduce the virus’s chance of spreading through fecal transmission. And Dr. Vivian Oehler is testing a broad panel of FDA-approved cancer drugs against COVID-19 to find treatments that could be effective in early-stage infection. Climb funding is critical to this important work.
I know this crisis has taken an enormous toll on all of us, but I’m inspired by the decisive actions of city and state officials, public health experts, Fred Hutch leaders, and our fellow citizens. These decisions are saving lives.
Thank you again for all you do for Fred Hutch and Climb to Fight Cancer. Please continue to take good care of yourself and your loved ones.
Climb to Fight Cancer Manager